UBS Says Tariff Concern Is Just One Factor Weighing on Dollar
Original Report
Questions around US trade policy are just one factor weighing on the dollar, according to UBS Chief European Equity Strategist and Head of Derivates Gerry Fowler. "It's not the most important driver...
Questions around US trade policy are just one factor weighing on the dollar, according to UBS Chief European Equity Strategist and Head of Derivates Gerry Fowler. "It's not the most important driver in markets at the moment," Fowler tells Bloomberg Television. "Currency depreciation is not just being driven by uncertainty, which was really the story of last year. It's now being driven by US investors investing offshore," he explains. (Source: Bloomberg)
Glass House Analysis
International economic policy has concrete impacts far beyond diplomatic circles. Tariffs show up in the price of goods at stores, supply chain disruptions affect whether products are on shelves, and trade tensions can mean job losses in export-dependent industries. The globalized economy means that decisions made abroad can affect workers and consumers domestically.
The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.
Enjoyed this analysis?
Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.
No spam. Unsubscribe anytime.
More Stories
Tax probe flags alleged $7.7bn sales suppression by India-based restaurants
As American Girl turns 40, Mattel grapples with bringing dolls into a new era
American Girl marks its 40th anniversary after five quarters of sales growth, but revenue remains far below its peak as Mattel faces industry pressures.
Pertamina, Halliburton to assess new drilling technology in Indonesia
Novo Nordisk sinks 13% after weight loss drug fails to match Eli Lilly's in trial
Novo Nordisk stock fell 13% Monday after it said its next-generation weight loss drug didn't meet its primary target.